12/ 23 Ved steady- state var den relative biotilgængelighed for doxazosin fra depottabletter - sammenlignet med den umiddelbare frigivelsesform - 54% ved 4 mg dosis og 59% ved 8 mg dosis.
At steady-state, the relative bioavailability of doxazosin from prolonged-release tablets compared to that of immediate release form was 54% at the 4 mg dose and 59% at the 8 mg dose.